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ABSTRACT
Adaptor protein (AP) complexes mediate key sorting decisions in the cell through selective incorpora-
tion of transmembrane proteins into vesicles. Little is known of the roles of AP-4, despite its loss of
function leading to a severe early onset neurological disorder, AP-4 deficiency syndrome. Here we
demonstrate an AP-4 epsilon subunit knockout mouse model that recapitulates characteristic neuroa-
natomical phenotypes of AP-4 deficiency patients. We show that ATG9A, critical for autophagosome
biogenesis, is an AP-4 cargo, which is retained within the trans-Golgi network (TGN) in vivo and in
culture when AP-4 function is lost. TGN retention results in depletion of axonal ATG9A, leading to
defective autophagosome generation and aberrant expansions of the distal axon. The reduction in the
capacity to generate axonal autophagosomes leads to defective axonal extension and de novo genera-
tion of distal axonal swellings containing accumulated ER, underlying the impaired axonal integrity in
AP-4 deficiency syndrome.
Abbreviations: AP: adaptor protein; AP4B1: adaptor-related protein complex AP-4, beta 1; AP4E1:
adaptor-related protein complex AP-4, epsilon 1; ATG: autophagy-related; EBSS: Earle’s balanced salt
solution; ER: endoplasmic reticulum; GFAP: glial fibrillary acidic protein; GOLGA1/Golgin-97/GOLG97:
golgi autoantigen, golgin subfamily a, 1; GOLGA2/GM130: golgi autoantigen, golgin subfamily a, 2; HSP:
hereditary spastic paraplegia; LC3/MAP1LC3B: microtubule-associated protein 1 light chain 3 beta;
MAP2: microtubule-associated protein 2; MAPK8IP1/JIP1: mitogen-acitvated protein kinase 8 interacting
protein 1; NEFH/NF200: neurofilament, heavy polypeptide; RBFOX3/NeuN (RNA binding protein, fox-1
homolog [C. elegans] 3); SQSTM1/p62: sequestosome 1; TGN: trans-Golgi network; WIPI2: WD repeat
domain, phosphoinositide interacting protein 2
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Introduction
Adaptor protein (AP) complexes have roles in the selection of
transmembrane proteins (cargo) for inclusion into vesicles. AP
complexes interact with sorting motifs within the cytoplasmic
facing tails of cargoes, leading to their specific enrichment at
sites on donor membranes. Upon motif recognition and binding
to cargoes, AP complexes recruit coat proteins which assemble to
generate free vesicles [1]. Of the 5 members of the AP complex
family, AP-1 and AP-2 are the best understood thus far, function-
ing in clathrin-dependent sorting from the trans-Golgi network
(TGN) and endocytosis from the plasma membrane, respectively.
Assembling as hetero-tetramers, AP complexes require the pre-
sence of all subunits to maintain functionality [2–4]. Indeed,
mutations in genes encoding all subunits of AP-4 (ε1; AP4E1, β1;
AP4B1, μ1;AP4M1 and σ1;AP4S1) have been identified as leading
to a complex form of hereditary spastic paraplegia (HSP) termed
AP-4 deficiency syndrome (henceforthAP-4 deficiency) [5,6]. AP-
4 deficiency patients present with early-onset severe intellectual
disability, absence of speech and progressive spasticity leading to
para- or tetraplegia [7]. Thinning of the corpus callosum axonal
tracts and ventriculomegaly are characteristic neuroanatomical
features arising fromwhite matter loss in AP-4 deficiency patients
[5,7–10]. Despite this severe pathology little is known of AP-4
other than its localization to the TGN in cell lines [11,12], and
mislocalization of AMPA receptors to autophagosomes in the
axons of a mouse model lacking ap4b1 [13]. The entire repertoire
of cargoes sorted by AP-4 in neurons and the functional conse-
quence of their altered handling and subsequent trafficking as
a result of disruption of the AP-4 complex remain poorly
understood.
Macroautophagy (henceforth autophagy) is the process by
which organelles and macromolecules are recycled for the main-
tenance of cellular homeostasis. Autophagy can be simplified
into 3 fundamental steps; induction, autophagosome biogenesis
and lysosomal degradation. Progression through the pathway is
in part mediated by the concerted recruitment of autophagy-
related (ATG) proteins [14], the sequence and necessity of which
are understood to be conserved in the neuron [15]. After the
induction of autophagy, membrane elongation from sites on the
endoplasmic reticulum (ER) forms a cup shaped phagophore
which incorporates cytosolic components [16]. Enclosure of the
expanding edges of the phagophore produces a double-
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membraned autophagosome, which can then fuse with late
endosomes and lysosomes to form degradative autolyso-
somes [17].
Intact and efficient autophagy is of critical importance to
post-mitotic cells, which cannot overcome proteotoxic burden
through cellular division [18]. Neurons may be exceptionally
susceptible to defects in autophagy due to their extreme
architecture, particularly the axon which can extend for dis-
tances up to a meter from the soma [19,20]. Autophagosomes
are constitutively generated in the axon, predominantly at its
most distal extremities [21,22]. In order to maintain this
localized biogenesis, machineries necessary for autophago-
some generation must be delivered to the distal axon; and
once completed, de novo generated autophagosomes retro-
gradely trafficked toward the soma for their clearance by
resident lysosomes. The sole mammalian transmembrane
ATG protein, ATG9A is thus of particular interest, as it relies
upon vesicular sorting and trafficking mechanisms for its
distribution. With its roles in phagophore extension and
autophagosome maturation [23,24], effective sorting and
delivery of ATG9A may be critical for the maintenance of
constitutive generation of autophagosomes in the distal axon.
Indeed, dysgenesis of the corpus callosum has recently been
identified in a CNS-specific atg9a knockout-mouse model
[25]. This defect in commissural axon crossing arising from
loss of ATG9A is highly reminiscent of the thinning of the
corpus callosum in AP-4 deficiency, raising the question of
whether the recent identification of altered ATG9A sorting in
cell lines lacking AP-4 function [26] is of relevance to the
pathological features of AP-4 deficiency.
Here we identify neuroanatomical defects in an ap4e1
knockout-mouse model mirroring those of AP-4 deficiency
patients. We show that ATG9A is a neuronal AP-4 cargo,
which is retained within the TGN in vivo and in culture as
a consequence of the disruption of AP-4 assembly. TGN
retention results in depletion of axonal ATG9A, reduction in
the capacity of axonal autophagosome generation and aber-
rant accumulation of ER within swellings in the distal axon.
This alteration in axonal autophagosome biogenesis likely
underlies defective axonal extension and integrity when AP-
4 function is lost, leading to axonal loss and the characteristic
phenotypes of AP-4 deficiency syndrome.
Results
Ap4e1 null mice recapitulate neuroanatomical features
of AP-4 deficiency
To elucidate themechanisms underpinning the pathology inAP-
4 deficiency, we first sought to characterize a mouse model
developed by the International Mouse Phenotyping
Consortium (IMPC) by targeting one of the 2 large subunits of
the AP-4 complex [27].Heterozygousmice carrying 1 copy of the
targeting cassette (Figure 1(a)) were crossed, generating litter
matched Ap4e1+/+ (WT) and ap4e1−/- (KO) animals (Figure S1
(a)). The AP4E1 subunit was confirmed to be entirely absent at
the protein level in KO animals (Figure 1(b)), and levels of the
AP4B1 subunit were reduced in tandem, indicating destabiliza-
tion of the entire AP-4 complex [2–4], and thus loss of AP-4
complex assembly. Using a beta-galactosidase assay we showed
the AP4E1 subunit to be expressed throughout all tissues during
embryonic development (Figure S1(b,c)), and across regions in
the adult brain (Figure S1(d)).
We next examined whether mice with loss of AP-4 function
phenocopied the characteristic neuroanatomical features of
AP-4 deficiency patients. To this end, we prepared sections
from WT and KO mice and examined their brain morphology
through staining of RBFOX3/NeuN and GFAP (Figure 1(c)).
We found dramatic and specific enlargement of the lateral
ventricles in KO animals by 1 month, and that this enlargement
did not appear to progress in severity by 4 months (Figure 1(d),
S1E; lateral ventricular area; 1 month: WT 52,216 ± 7,092 μm2,
KO 528,509 ± 130,084 μm2, p = 0.0064; 4 month: WT
235,874 ± 67,610 μm2, KO 650,456 ± 76,361 μm2, p = 0.015;
Figure S1(e); area of third ventricle: WT 297,649 ± 51,048 μm2,
KO 278,361 ± 34,709 μm2, p = 0.78; area of fourth ventricle:
WT 9,966 ± 2,333 μm2, KO 9,793 ± 1815 μm2, p = 0.96; t-test).
Given this similarity to patients’ ventriculomegaly, we next
examined whether KO mice additionally exhibited the charac-
teristic thinning of the corpus callosum by staining brain sec-
tions using FluoroMyelin to reveal axon tracts (Figure 1(e)).
Robust thinning of the corpus callosum axonal tracts was
evident at 1 month in KO animals, which did not progress in
severity by 4 months (Figure 1(f); corpus callosum thickness
FluoroMyelin; 1 month: WT 302.5 ± 8.26 μm, KO 197.4 ± 8.25,
p = 0.0008; 4 month: WT 317.7 ± 5.74 μm, KO 225.4 ± 12.52,
p = 0.0026; t-test). We confirmed that this was as a result of the
loss of axons by staining sections against the axon-resident
neurofilament, NEFH/NF200 (Figure 1(g,h); corpus callosum
thickness NEFH/NF200:WT 300 ± 10.7 μm, KO 212 ± 12.7 μm,
p = 0.0007; t-test). In addition to the corpus callosum, thinning
of the apical anterior commissure and external capsule axonal
tracts was evident at 1 month in KO animals (Figure S1(f, g);
anterior commissure area: WT 80,200 ± 12,050 μm2, KO
45,900 ± 4,950 μm2, p = 0.0272; external capsule length: WT
142.3 ± 6.2 μm2, KO 97.22 ± 4.29 μm2, p < 0.0001; t-test),
whereas no alteration was found in the lateral optic tract
(Figure S1(h); lateral optic tract: WT 38,500 ± 2716 μm, KO
37,140 ± 3,890 μm; p = 0.78).
The thinning of commissural axon tracts and enlargement of
lateral ventricles led us to question whether these defects arise due
to defective axon development, or through extensive neuronal cell
loss. To address this, we quantified neuronal cell numbers within
regions of KO brain at 1 and 4 months. We found that cortical
neuronal numbers in KO were indistinguishable from WT ani-
mals both at 1 and 4 months (Figure S1(i); relative cortical neuro-
nal cell number; 1 month: WT 1 ± 0.053, KO 1.053 ± 0.033,
p = 0.44; 4 month: WT 1 ± 0.09, KO 0.94 ± 0.057, p = 0.63;
t-test). Neither was there a detectable reduction in neuronal cell
number in major regions of the hippocampus at 1 month (Figure
S1(j, k); relative neuronal cell number; CA1: WT 1 ± 0.11, KO
1.05 ± 0.031, p = 0.72; CA3: WT 1 ± 0.077, KO 0.99 ± 0.057,
p = 0.92; DG:WT 1 ± 0.059, KO 0.97 ± 0.093, p = 0.78; t-test). We
did note however a small decrease in cell number in the CA1
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region of the hippocampus at 4 months, whereas CA3 and DG
regions were unaffected (Figure S1(j, l); relative neuronal cell
number; CA1: WT 1 ± 0.037, KO 0.85 ± 0.031, p = 0.036; CA3:
WT 1 ± 0.076, KO 0.79 ± 0.045, p = 0.082; DG:WT 1 ± 0.073, KO
0.91 ± 0.14, p = 0.59; t-test). To further examine whether there was
evidence of neuronal cell death in KO brains, we investigated
astrocytic proliferation in regions of the hippocampus.No increase
in astrocyte resident GFAP immunoreactivity was evident at
1 month nor 4 months (Figure S1(j,m,n); relative GFAP immu-
noreactivity; 1 month CA1: WT 1 ± 0.11, KO 0.93 ± 0.098,
p = 0.66; 1 month CA3: WT 1 ± 0.086, KO 1.02 ± 0.15, p = 0.91;
1 month DG: WT 1 ± 0.18, KO 0.94 ± 0.068, p = 0.77; 4 month
CA1:WT 1 ± 0.055, KO 0.82 ± 0.086, p = 0.15; 4 month CA3:WT
1 ± 0.15, KO 0.97 ± 0.11, p = 0.9; 4 month DG:WT 1 ± 0.083, KO
0.82 ± 0.095, p = 0.22; t-test), indicating that there was no astro-
gliosis and thus no evidence of neurodegenerative cell death inKO
animals. The identification of enlarged lateral ventricles and con-
current thinning of the corpus callosum are highly reminiscent of
the characteristic features of AP-4 deficiency patients [7], support-
ing ap4e1 KO mice as a model of AP-4 deficiency. We show that
these anatomical defects are evident at 1 month and have no
progressive element in our model by 4 months of age.
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Figure 1. ap4e1 null mice recapitulate neuroanatomical features of AP-4 deficiency. (a) Schematic of promoter driven ap4e1 KO tm1b allele, showing removal of
critical exon 3. (b) Western blot prepared from AP-4 line showing total loss of AP4E1 protein and concurrent loss of AP4B1 at protein level in ap4e1 KO animals. (c, d)
Sections prepared from animals at 1 and 4 month timepoints stained against RBFOX3/NeuN and GFAP showing lateral ventricular enlargement in KO. Scale bar: 200
μm. (D) Quantification of relative area of lateral ventricle (n = 3/5 animals 1 and 4 months). (e, f) Axons stained using FluoroMyelin at 1 month and 4 months
showing thinning of corpus callosum tracts in KO. Scale bar: 200 μm. (f) Quantification of thickness of corpus callosum (n = 3 animals). (g, h) Commissural crossing
axons at 1 month, stained against Neurofilament-200 (NEFH/NF200). Scale bar: 100 μm. (h) Quantification of thickness of corpus callosum (n = 5 animals). Quantified
data expressed as mean ± SEM. Statistical analysis: Two-tailed unpaired Student’s t-test, *p < 0.05, **p < 0.01 and ***p < 0.001. CC – corpus callosum.
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ATG9A trafficking is affected in vivo in ap4e1 KO mice
We next questioned what essential functions of AP-4 or its
cargoes are lost that leads to the specific and severe axonal
pathology evident in AP-4 deficiency. Intriguingly, the trans-
membrane protein ATG9A has been identified as a putative
AP-4 interactor by mass spectroscopy [28] and recent work
has highlighted that ATG9A has altered distribution in cell
lines lacking AP-4 [26,29]. Given the localization of AP-4 to
the TGN, and the necessity of sorting transmembrane ATG9A
from the TGN to the distal axonal for local autophagosome
generation; we sought to elucidate whether this alteration of
ATG9A handling was evident in vivo, and thus potentially the
mechanism underpinning the pathology in AP-4 deficiency.
Confirming the interaction between ATG9A and the
AP-4 complex by Co-IP of ATG9A and AP4E1 from
adult mouse brain (Figure 2(a)), we showed that ATG9A
is an AP-4 cargo in the brain. Interestingly, in these
immunoprecipitation experiments we also noticed that
the protein level of ATG9A was robustly increased in
our input samples. Preparing lysates from KO hippocam-
pus at 1 month we confirmed the increase in ATG9A
protein in KO brain (Figure 2(b,c); relative ATG9A pro-
tein: WT 1 ± 0.23, KO 2.33 ± 0.05, p = 0.0046; t-test),
indicating that not only did ATG9A interact with AP-4,
but its protein levels were affected by loss of AP4E1.
Indeed, ATG9A was increased at protein level in all
regions of the brain investigated (Figure S2(a)), and
throughout other tissues including the heart, liver and
lung in KO animals (Figure S2(b)). Investigating brain
sections from mice at 1 month, we found not only
a marked increase in the immunoreactivity of ATG9A in
KO brain (Figure 2(d)), but notably that ATG9A appeared
to accumulate within distinct structures in neuronal cell
layers of the cortex and CA1 regions of KO brain (Figure
2(e,f)). Thus, it is evident that loss of AP-4 function
dramatically alters the amount and localization of
ATG9A in vivo in ap4e1 KO animals, suggesting that
ATG9A function may be affected in AP-4 deficiency.
Figure 2. ATG9A handling is affected in vivo in ap4e1 KO mice. (a) Endogenous co-immunoprecipitation of AP4E1 with ATG9A from mouse brain, showing interaction
between AP-4 and ATG9A (n = 3 independent experiments). (b) Western blot of ATG9A in hippocampus at 1 month showing increase in KO animals. (c)
Quantification of relative ATG9A protein (n = 3 animals). (d) Sections prepared from AP-4 line at 1 month stained against ATG9A and NEFH/NF200, showing
increased immunoreactivity and accumulation of ATG9A within neuronal cell layers. Scale bars: 200 and 50 μm (e) High magnification showing accumulation of
ATG9A within cortex and (f) CA1 of hippocampus. Scale bar: 20 μm (n = 5 animals). Quantified data is expressed as mean ± SEM. Statistical analysis: Two-tailed
unpaired Student’s t-test, **p < 0.01.
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ATG9A accumulates within the TGN in ap4e1 KO neurons
Given the accumulation of ATG9A in KO neurons in vivo,
we sought to identify the compartment within which
ATG9A was retained. To address this, we examined cul-
tured hippocampal neurons, staining against ATG9A and
the neuron specific dendritic marker, MAP2 (Figure 3(a)).
Similar to our in vivo findings, endogenous ATG9A was
increased in KO neurons (Figure 3(a,b); relative neuronal
ATG9A signal: WT 1 ± 0.06, KO 2.8 ± 0.2, p < 0.0001;
t-test), and other cell types including astrocytes (Figure S3
(a); relative astrocytic ATG9A signal: WT 1 ± 0.11 KO
2.42 ± 0.27, p < 0.0001; t-test).
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Figure 3. ATG9A accumulates within the TGN in ap4e1 KO neurons. (a) DIV-8 cultured hippocampal neurons stained against ATG9A and MAP2. Inset panels show
zoomed regions indicated by dashed boxes of cell body and accumulation of ATG9A. Scale bars: 20 μm; crop: 5 μm. (b) Quantification of relative ATG9A in neuronal
soma (n = 40/20 neurons WT/KO). (c) SIM of DIV-8 cultured hippocampal neurons stained against ATG9A, cis-Golgi marker GOLGA2/GM130 and trans-Golgi marker
GOLGA1/GOLG97. Dashed boxes indicate region in magnified panels, showing ATG9A overlapping GOLGA1/GOLG97 in KO. (d) Intensity linescans demonstrate ATG9A
retention within the TGN in KO neurons. Scale bars: 5 μm; crop: 0.5 μm (n = 3 experimental repeats). (e) Reconstitution of AP-4 complex with expression of MYC-
tagged FL AP4E1 and AP-4 deficiency associated AP4E1V454X Ap4e1 constructs (refer to Fig S3B). Dashed boxes indicate region in magnified panels. Scale bars: 5 μm;
crop: 2 μm. (f) Quantification of relative ATG9A in soma of KO neurons in rescue conditions (n = 26/26/23 neurons FL AP4E1/AP4E1V454X/UT). (g) Western blot of
lysates prepared from cortical neurons after 4, 8 and 12 days in culture probed against ATG9A. (h) Quantification of relative levels of ATG9A (n = 3/4 embryos WT/
KO). Quantified data is expressed as mean ± SEM. Statistical analysis: (b, h) Two-tailed unpaired Student’s t-test, (f) Kruskall-Wallis test, *p < 0.05 and ***p < 0.001.
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Given the known localization of AP-4 to the TGN in cell
lines, we hypothesized that the sorting of ATG9A may be
dependent on AP-4, and thus ATG9A may be retained within
the TGN in neurons [26,29,30]. We firstly confirmed neuro-
nal AP-4 localization at the TGN, through staining of endo-
genous AP4E1 and the TGN resident marker, GOLGA1/
Golgin-97/GOLG97 (Figure S3(b)). Following this, we used
a super-resolution approach (structured illumination micro-
scopy, SIM) to clarify the ATG9A compartment in KO neu-
rons. Staining the cis and trans faces of the Golgi network
(GOLGA2, and GOLGA1 respectively), we found that ATG9A
was specifically retained in the TGN of KO neurons (Figure 3
(c,d)). In contrast, ATG9A exhibited a vesicular localization in
WT neurons, highlighting the dramatic alteration in ATG9A
sorting and localization when AP-4 function is lost.
To confirm that TGN retention of ATG9A arose as a result
of failure of AP-4 dependent sorting, we opted to reconstitute
the AP-4 complex through exogenous expression of the
AP4E1 in KO neurons. We cloned N-terminally tagged
AP4E1 (Figure S3(b)), and through transient transfection
examined the effect upon ATG9A retention (Figure 3(e)).
Reconstitution of the AP-4 complex with a full-length (FL)
AP4E1 was able to entirely rescue ATG9A retention, and its
levels in KO neurons. However, an AP4E1V454X construct
carrying a premature termination mutation identified in an
AP-4 deficiency cohort [10], failed to restore ATG9A reten-
tion and levels in KO neurons (Figure 3(e,f); relative ATG9A
in soma: FL 1 ± 0.06, AP4E1V454X 2.48 ± 0.22, untransfected
[UT] 2.81 ± 0.19, p < 0.0001 AP4E1V454X/UT to FL, NS
between AP4E1V454X and UT; Kruskall-Wallis). Thus, func-
tional AP-4 assembly is necessary for the TGN exit of ATG9A
both in vivo and in cultured neurons. Does this retention lead
to the increased levels of ATG9A evident in KO animals?
Preparing lysates from neurons at DIV-4, DIV-8 and DIV-
12 we identify that the level of ATG9A increased progressively
over time (Figure 3(g,h); relative ATG9A protein; DIV-4: WT
1 ± 0.22, KO 1.27 ± 0.35, p = 0.55; DIV-8: WT 0.95 ± 0.16,
KO 1.88 ± 0.18, p = 0.014; DIV-12: WT 1.6 ± 0.29, KO
2.89 ± 0.22, p = 0.012; t-test), confirming that retention within
the TGN results in the accumulation of ATG9A protein.
Defective autophagosome maturation in ap4e1 KO
neurons
Having elucidated the necessity of AP-4 for the sorting of
ATG9A from the TGN, we next sought to understand what
effect this retention had on the distribution and function of
ATG9A in AP-4-deficient neurons. Staining dendritic and
axonal compartments using MAP2 and NEFH/NF200 respec-
tively, we found a specific reduction in the axonal pool of
ATG9A (Figure 4(a,b); ATG9A vesicles per 10 μm2; axonal:
WT 5.42 ± 0.32, KO 3.49 ± 0.39, p = 0.0009; dendritic: WT
4.47 ± 0.25, KO 4.18 ± 0.26, p = 0.43; t-test). Notably,
dendritic ATG9A in KO was at parity with WT levels,
whereas axonal ATG9A was reduced despite the near 3-fold
increase in ATG9A within neuronal somas (Figure 3(b)).
Together these results identify a clear reduction in the axonal
pool of ATG9A, whereas dendritic ATG9A appears
unaffected.
Given the known functions of ATG9A, what does this
reduction in its axonal distribution mean for the capacity of
autophagosome biogenesis within this compartment? To
address this we examined nascent autophagosome maturation
within the distal-most portions of the axon. Transient trans-
fection of RFP-LC3 (MAP1LC3B), which associates with
autophagosomes from early through to late maturation states,
provided a robust marker for tracking autophagosomes
throughout their lifespan [15]. Maturing autophagosomes
initially exhibit bidirectional movement [21] prior to switch-
ing to robust dynein driven retrograde movement mediated
by MAPK8IP1/JIP1 [31,32]. We found nascent autophago-
somes in the distal WT axon to exhibit classical bi-
directional motility with net retrograde displacement towards
the neuronal soma (Figure 4(c), movies S1 and S2) [21]. In
KO axons however, we found a reduction in the number of
motile LC3-positive structures (Figure 4(c,d); RFP-LC3 struc-
tures; Total: WT 0.88 ± 0.35, KO 1 ± 0.47, p = 0.51; motile:
WT 0.43 ± 0.2, KO 0.32 ± 0.16, p = 0.044; Mann-Whitney U),
and that these nascent autophagosomes exhibited a reduced
propensity to move retrogradely toward the soma, both in
absolute retrograde displacement (Figure 4(c,e); absolute ret-
rograde displacement: WT 10.43 ± 1.99 μm, KO 1.139 ± 1.42
μm, p < 0.0001; Mann-Whitney U test) and in individual
retrograde runs, whereas anterograde movements were unal-
tered (Figure 4(f); anterograde run length: WT 15.89 ± 1.28
μm, KO 11.96 ± 1.16 μm, p = 0.686; retrograde run length:
WT 25.75 ± 1.59 μm, KO 12.58 ± 1.055 μm, p < 0.0001;
Mann-Whitney U). Autophagosomes in KO axons were less
motile, with reduced total run length (Figure 4(g); total run
length per autophagosome: WT 41.64 ± 2.11 μm, KO
24.54 ± 1.72 μm, p < 0.0001; Mann-Whitney U test), spent
more time stationary (Figure 4(h): proportion time stationary:
WT 58.75 ± 1.6%, KO 65.82 ± 2.077%, p = 0.0055; Mann-
Whitney U) and less time moving retrogradely than in the
WT axon (Figure 4(h); time moving anterogradely: WT
17.80 ± 1.17%, KO 18.66 ± 1.55%, p = 0.45; time moving
retrogradely: WT 23.45 ± 1.29%, KO 15.52 ± 1.13%,
p = 0.0003; Mann-Whitney U test). Importantly, anterograde
motility and trafficking of RFP-LC3 structures in KO axons
was entirely indistinguishable from that of WT in run lengths,
in their proportion of time moving and velocity of individual
runs (Figure 4(h); anterograde velocity; WT 0.29 ± 0.026 μm/
s, KO 0.27 ± 0.035 μm/s, p = 0.38; mean retrograde velocity;
WT 0.42 ± 0.02 μm/s, KO 0.31 ± 0.032 μm/s, p < 0.0001;
Mann-Whitney U test). Given that anterograde movements
were normal, we conclude that trafficking is not affected
per se, but that there is a specific defect in retrograde move-
ments of nascent autophagosomes that depends on LC3-
lipidation state. Collectively these parameters identify
a critical alteration in the maturation state of nascent autop-
hagosomes in KO axons, owing to the reduced provision of
axonal ATG9A as a result of the loss of AP-4 function.
We next examined whether alteration to autophagosome
maturation impacted upon the autophagic capacity of KO
neurons directly through investigation of autophagic flux in
cultured neurons. DIV-8 neurons were treated in the presence
of 100 nM bafilomycin A1 (BafA1) with 250 nM rapamycin
(Rap) or starved in EBSS to induce autophagy (Figure 4(j)),
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Figure 4. Defective autophagosome maturation in ap4e1 KO neurons. (a) Endogenous ATG9A vesicles in axons and dendrites, stained using NEFH/NF200 and MAP2
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levels relative to own 0 h control. (m) Western blot of lysates prepared from KO hippocampus at 1 month showing no alteration in endogenous LC3 levels nor
processing. (n) Quantification of LC3-II:I ratio, LC3-II and LC3-I (n = 3 animals). (o) Blot of endogenous SQSTM1/p62 in KO hippocampus at 1 month showing
reduction in AP-4 KO. (p) Quantification of relative protein level of SQSTM1/p62 (n = 3 animals). Quantified data is expressed as mean ± SEM. Statistical analysis: (b,
n and p) Two-tailed unpaired Student’s t-test, (d – i, k and l) Mann-Whitney test, *p < 0.05, **p < 0.01 and ***p < 0.001.
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and lipidated LC3 and SQSTM1/p62 levels examined by wes-
tern blotting. A significantly reduced rate of LC3 lipidation
was revealed in KO neurons, both basally, and with the
induction of autophagy with rapamycin or EBSS (Figure 4(j,
k); Table S1). Further, we found slowed SQSTM1/p62 accu-
mulation in KO neurons during these treatments (Figure 4(j,
l); Table S1). Interestingly, steady state levels of LC3 were
unaffected in cultured KO neurons (Figure 4(j,k)), but also
in hippocampal lysates prepared from animals at 1 month
(Figure 4(m,n); relative LC3-II:I ratio: WT 1 ± 0.012, KO
0.82 ± 0.13, p = 0.24; relative LC3-II: WT 1 ± 0.077, KO
1 ± 0.22, p = 0.99; relative LC3-I: WT 1 ± 0.089, KO
1.21 ± 0.14, p = 0.29; t-test), in agreement with data recently
reported [30]. Further, we found a robust decrease in
SQSTM1/p62 in KO animals at 1 month (Figure 4(o,p); rela-
tive SQSTM1/p62 protein: WT 1 ± 0.11, KO 0.59 ± 0.05,
p = 0.025; t-test), similar to that reported in ap4b1 null mice
[13]. The level of WIPI2 in the KO was at parity with WT
animals (Figure S4(a,b); relative WIPI2 protein: WT
1 ± 0.066, KO 1.16 ± 0.12, p = 0.32; t-test) and we found no
accumulation of ubiquitinated proteins in KO brain (Figure
S4(c,d); relative ubiquitin protein: WT 1 ± 0.14 KO
1.11 ± 0.05, p = 0.49; t-test). Together these results indicate
that AP-4 dependent ATG9A sorting is required for proper
induction of autophagy in neurons, and to maintain autopha-
gosome generation in the distal axon.
Using endogenous WIPI2 as a marker of early sites of
autophagosome generation [33], we investigated autophago-
some generation within neuronal somas. We identified
a reduction of WIPI2 sites in KO somas (Figure S4(e,f);
relative number of WIPI2 puncta: WT 1 ± 0.075, KO
0.74 ± 0.094, p = 0.031; Mann-Whitney U) and a reduction
in the number of autophagosomes in KO neuronal somas, as
evidenced by a reduction in the number of LC3 puncta
(Figure S4(e,f); relative number LC3 puncta: WT 1 ± 0.097,
KO 0.71 ± 0.12, p = 0.011; Mann-Whitney U). Indeed, despite
this reduction in the numbers of puncta of both WIPI2 and
LC3 in the soma, neither exhibited alteration in their size
(Figure S4(e,g); size of LC3 puncta: WT 0.084 ± 0.0044 μm2,
KO 0.078 ± 0.006 μm2, p = 0.17; size of WIPI2 puncta: WT
0.084 ± 0.0049 μm2, KO 0.094 ± 0.0085 μm2, p = 0.42; Mann-
Whitney U), and LC3 associated with WIPI2 in KO somas
indistinguishably from WT (Figure S4(e,h); proportion LC3
associated with WIPI2: WT 13.5 ± 2.3%, KO 15.3 ± 3.77,
p = 0.96; Mann-Whitney U). Thus, sites of biogenesis in the
soma as marked by WIPI2 appear functional but are reduced
in number leading to a reduction in de novo autophagosome
generation and thus flux. Together, these results indicate
a slowing of autophagosome biogenesis through altered
ATG9A sorting in ap4e1 KO, resulting in fewer autophago-
some being generated. However, once generated autophagic
degradation in KO neurons appears to be normal.
Axon specific defects in ap4e1 KO neurons
Does the reduction in the capacity of autophagosome genera-
tion underlie the overt axonal pathology evident in AP-4
deficiency? To answer this, we investigated the integrity of
hippocampal neurons in our AP-4 deficiency model. Through
transient transfection of GFP we revealed the entire morphol-
ogy of cultured hippocampal neurons (Figure 5(a)) and exam-
ined their integrity after 14 days in culture. We identifed no
alteration in dendritic complexity (Figure 5(b); number of
intersections per 10 μm sholl: NS; two-way ANOVA), total
dendritic length (Figure 5(a,c); total dendritic length: WT
2807 ± 326.1 μm, KO 2730 ± 324.2 μm, p = 0.87; t-test) nor
branch number (Figure 5(a,d); total dendritic branches: WT
55.6 ± 4.9, KO 51.3 ± 5.1, p = 0.56; t-test). Using Golgi silver
staining of slices prepared from our model at 4 months, we
reconstructed entire dendritic arbors of CA1 hippocampal
neurons (Figure S5(a)). Similarly to our findings in culture,
we found no significant alteration in the complexity of apical
(Figure S5(b); apical dendritic length per 10 μm; NS; two way
ANOVA) nor basal dendrites (Figure S5(c); basal dendritic
length per 10 μm; NS; two way ANOVA), total lengths of both
apical and basal dendrites (Figure S5(d); total dendritic length;
apical: WT 1529 ± 206 μm, KO 1732 ± 312 μm, p = 0.6; basal:
WT 1037 ± 125 μm, KO 1058 ± 133 μm, p = 0.91; t-test), nor
numbers of dendritic branches in KO neurons (Figure S5(e);
total dendritic branches; apical: WT 15.9 ± 2.1, KO 15.2 ± 2.7,
p = 0.85; basal: WT 12.4 ± 1.4, KO 11.3 ± 1.5; p = 0.6; t-test).
Together we show that dendritic morphology is unaffected by
the loss of AP-4 function both in vivo and cultured neurons.
We next examined whether the reduced capacity of axonal
autophagosome maturation gives rise to a specific alteration
to axonal integrity and thus the axonal pathology of AP-4
deficiency. Investigating cultured neurons at DIV-4, after the
specification of the axonal process, we were able to examine
the entirety of the axonal extension of an individual neuron.
We identified decreased axon length in KO neurons (Figure 5
(e,f): total axonal length; WT 963.5 ± 76.2 μm, KO
679.2 ± 51.9 μm, p = 0.0055; t-test), and in axon branching
(Figure 5(e,g): number of axonal branches: WT 5.6 ± 3.2, KO
3.7 ± 1.9, p = 0.023; Mann-Whitney U test). Despite this, at
this age in culture nascent dendritic processes of KO neurons
were unaltered in their length (Figure 5(e,h); nascent dendri-
tic length: WT 412 ± 37.6 μm, KO 385 ± 19.1 μm, p = 0.5;
t-test) and branching (Figure 5(i): nascent dendritic branches:
WT 10.4 ± 1.1, KO 10.0 ± 0.77, p = 0.772; t-test), highlighting
that axonal extension is specifically affected. This reduction in
axonal extension and branching may underpin the ventricu-
lomegaly and thinning of the corpus callosum characteristic of
AP-4 deficiency.
Distal generation of axonal swelling, comprised of ER
accumulations in AP-4 deficiency
In examining axonal extension in culture, we noted that KO
axons exhibited dramatic distal swellings (Figure 5(e,j,k); axo-
nal swellings: WT 1.5 ± 0.61, KO 7.2 ± 1, p < 0.0001; Mann-
Whitney U test), that were not seen in dendritic processes.
These swellings were also evident in more mature cultures
(Figure S5(f,g); axonal swellings per 100 μm: WT 0.23 ± 0.04,
KO 1.1 ± 0.2, p = 0.005; t-test). Do these arise directly as
a result of reduced axonal ATG9A (Figure 4(a)), or is there
contribution from other AP-4 cargoes? To address this, we
attempted to artificially drive increased axonal ATG9A
through transient exogenous expression of HA-ATG9A
(Figure S5(h)). We found that expression of HA-ATG9A for
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2 days was sufficient to increase axonal delivery of ATG9A in
KO axons, presumably through inclusion of exogenous
ATG9A into other axonally-targeted vesicles (Figure S5(h,i);
relative axonal ATG9A: untransfected (UT) 1 ± 0.19 HA-ATG
9 4.8 ± 0.68, p < 0.0001; Mann-Whitney U test). As a result of
this transient increase in axonal ATG9A, we found
a significant reduction in the number of axonal swellings in
KO axons (Figure 5(l,m); swellings per neuron: UT 8.1 ± 0.76,
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HA-ATG9 5.5 ± 0.83, p = 0.0075; Mann-Whitney U test),
supporting ATG9A as the primary contributor to axonal
swelling in KO neurons. Intriguingly, distal axonal swellings
have previously been identified in mouse models ablated of
ATG5 and ATG7 function [34,35]; ATG5, ATG7 and ATG9A
have roles in autophagosome biogenesis post the initiation
machinery [14,36], suggesting that axonal swellings may
arise where autophagosome biogenesis has been initiated,
but is stalled at this stage. To elucidate the nature of axonal
swelling in KO neurons, we examined growing axons using
long-term imaging of neurons transiently transfected with
GFP for durations of 6 h (Figure 6(a), movies S3, S4).
Strikingly, this revealed that swellings are generated de novo
in ap4e1 KO axons, emerging either directly from, or in close
proximity to the advancing growth cone. These generated
swellings were non-motile and persisted for durations in the
range of hours (Figure 6(a), movies S3, S4). Interestingly, we
found that growing WT axons also have the propensity to
generate smaller, more transient swellings (Figure 6(b), S6A
movies S5, S6, S7, S8), which disassembled rapidly when
compared to those of KO axons.
We next addressed what these de novo generated distal
swellings comprised of using a correlative light and electron
microscopy (CLEM) approach. Identifying individual
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arrows. Swellings disassemble over time, as indicated by blue arrows (Refer to Movies S3 and S4). Scale bar: 5 μm. (b) Swellings formed in WT axons disassemble
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swellings in cultured neurons (Figure 6(c), S6(b)), we found
that swellings in KO axons contained aberrantly accumulated
ER (Figure 6(b-d)); whereas expanded portions of distal WT
axons were largely devoid of ER (Figure S6(b)). Intriguingly,
we also identified that these accumulations were incorporated
into autophagosomes in KO axons (Figure 6(e), 6Eii, S6(e)).
These findings, in combination with our data showing
impaired autophagosome generation and autophagic flux,
suggest that the accumulation of ER membranes in the axonal
swellings of ap4e1 KO axons is due to the reduced capacity of
autophagosome generation where AP-4 dependent axonal
ATG9A provision is reduced.
Discussion
Despite mounting evidence implicating impaired autophagy
in neurodevelopmental and neurodegenerative disease [37–
42], autophagy remains poorly understood mechanistically
in the neuron. The post-mitotic nature of the neuron, its
extreme architecture, and limited capacity to upregulate
autophagy [43] underlies its increased vulnerability to
impaired autophagic flux. Here we show that failure of AP-4
mediated ATG9A sorting from the TGN depleted axonal
ATG9A, impairing axonal autophagosome biogenesis. This
resulted in aberrant accumulation of ER in de novo generated
distal axonal swellings, likely underpinning the reduction in
axonal extension, and neuroanatomical defects evident in our
AP-4 deficiency mouse model. We provide evidence toward
pathology in AP-4 deficiency arising through this specific
reduction in the capacity of autophagic clearance in the axon.
In the present study, we identified neuroanatomical defects
mirroring those of AP-4 deficiency patients. We show that
these arose developmentally in our ap4e1 KO mouse; thinning
of the corpus callosum and lateral ventricular enlargement
were evident by 1 month of age, and did not progress in
severity by 4 months. Further, we show that these features
did not result from neurodegenerative cell loss, as evidenced
by the distinct lack of astrogliosis in KO animals at 4 months.
Indeed, gross anatomy of KO mice was normal throughout
development and into adulthood, despite their prominent
neuroanatomical defects. We find that the thinning of axonal
tracts in vivo arose as a result of the loss of axonal density;
hippocampal neuron cultures revealed reduced axonal exten-
sion and branching at the level of the individual neuron.
Strikingly however, the complexity and integrity of the den-
dritic arbors of hippocampal neurons were entirely indistin-
guishable from WT. The overt axonal pathology in AP-4
deficiency likely results from the specific depletion of axonal
ATG9A in KO neurons; ATG9A being dramatically TGN
retained where AP-4 is lost. We clarify that this is a feature
of AP-4 deficiency by showing that functional AP-4 is
required for the exit and sorting of ATG9A in neurons.
Reconstitution of the AP-4 complex through exogenous
expression of AP4E1 in KO neurons rescued ATG9A reten-
tion, whereas a pathological mutation carrying subunit was
unable to do so [10]. Together, our findings reveal a critical
role for AP-4 in ATG9A sorting in the neuron, highlighting
the importance of axonal distribution of ATG9A for the
maintenance of axonal integrity.
Maintenance of constitutive distal autophagosome biogen-
esis in the axon requires that the delivery of newly synthesized
cargoes from the soma is tightly balanced with efficient clear-
ance from this compartment. We show here that where the
provision of ATG9A to the axon is reduced, the resulting
slowing of autophagosome maturation lead to de novo gen-
eration of distal axonal swellings. These swellings comprised
of expanded portions of ER are transient in their nature, being
consumed through incorporation into autophagosomes.
Swellings are immobile, persisting at their sites of formation
for their duration. Thus, their collapse is not accounted for by
re-distribution of constituent ER to more distally generated
swellings, but likely through incorporation into autophago-
somes. Together these results implicate a potential reduction
in the capacity of axonal clearance of ER (reticulophagy), in
the pathology of our model through the failure of AP-4
mediated ATG9A sorting. During the preparation of this
manuscript we became aware of a study also identifying
similar neuroanatomical defects in ap4e1 KO mice [30].
Interestingly, the authors identify that over-expression of
aggregate prone n-terminal fragments of huntingtin leads to
its accumulation within axonal swellings. The identification
herein of the dynamic nature of axonal swelling formation
through slowing of autophagosome maturation as a result of
reduced provision of axonal ATG9A provides the mechanism
for this accumulation, and further adds to the evidence of
a reduced capacity of autophagic clearance from the axon.
Distal axonal swellings are emerging as a hallmark in
mouse models ablated of proteins critical for early stages of
autophagosome biogenesis: atg5, atg7, atg9a [25,34,35], and
are reported in multiple models of HSP [44–46]. Aberrant
accumulation of ER is also found within the axonal swellings
of atg5 null mice [34], and ER expansion is evident where
ATG5 or BECN1 are silenced [47]. Moreover, factors critical
for ER shaping and remodeling including ATL1, REEP1,
SPAST, RTN2 are implicated in over 60% of all HSP cases
[48–51], and evidence is emerging that ATL1-dependent
remodeling is necessary for selective autophagosomal incor-
poration of ER [52]. Given that autophagosomes form from
ER sites [15,16], and ER resident proteins modulate autopha-
gosome biogenesis [53] it remains to be ascertained in our
model whether ER accumulated due to the reduction in the
capacity to consume it [47,54,55]; or whether the reduced
capacity of autophagosome biogenesis leads to reduced incor-
poration of ER into the autophagosomal membrane itself.
Together, our model adds to the evidence implicating ER
shaping, remodeling and additionally reticulophagy in the
maintenance of axonal integrity in HSP [51,56–60].
70% of complex HSP patients presenting with progressive
spasticity, intellectual impairment and thin corpus callosum
are accounted for by mutations in SPG11/spatacsin and
ZFYVE26/spastizin [6], both having roles in autophagosome
maturation and endolysosomal function [57]. Thin corpus
callosum has also been identified in autophagy-related CNS
specific KO mouse models including ulk1 ulk2 double
knockout and atg9a [25,61], and axonal extension is con-
comitantly reduced in neurons cultured from these lines
[25,56,62,63]. Given this striking similarity to ap4e1 KO
mice, we provide evidence towards thinning of the corpus
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callosum in AP-4 deficiency arising developmentally through
defective axonal extension as a result of reduced axonal
autophagosome biogenesis. Constitutive knockout of atg5,
atg7, atg9a and ulk1/2 double knockout leads to peri-natal
lethality [64–68], whereas AP-4-deficient mice, and indeed
patients, survive into adulthood. Importantly, in the present
study we show that autophagosome biogenesis was slowed,
but not entirely blocked. Sites of autophagosome maturation
as marked by WIPI2 were reduced in the soma, but appear
functional, giving rise to fewer autophagosomes. This
remaining autophagic capacity was able to sustain dendritic
integrity even by 4 months in vivo, whereas axonal defects
manifested by 4 days in culture. Given the progressive nat-
ure of ATG9A accumulation in KO neurons, we speculate
that increased ATG9A resident within the TGN membrane
leads to its stochastic incorporation into vesicles mediated
by other carriers. As a result, sufficient vesicular ATG9A is
delivered somatodendritically in KO neurons to maintain
effective autophagy within this compartment, whereas axon-
ally destined vesicular delivery is reduced. Indeed, in
C. elegans where AP-4 is not evolutionarily conserved [69],
axonal delivery of ATG9A is also critical for autophagosome
biogenesis and axon outgrowth [70].
Interestingly, we were able to partially rescue axonal swelling
in KO neurons through overexpression of exogenous ATG9A,
which increased axonal delivery presumably through inclusion
of ATG9A into other axonally targeted vesicles at the TGN.
Thus, promoting axonal ATG9A delivery from the TGN repre-
sents an intriguing therapeutic possibility either through
increased ATG9A biosynthesis or manipulation of the recently
identified AP-4 cargo adaptor RUSC2 [29]. Whilst we cannot
entirely rule out whether other unidentified AP-4 cargoes con-
tribute to the alterations in autophagosome generation evident
in the axon, the limited AP-4 cargo repertoire emerging in recent
studies [29] and the known roles of ATG9A make it the prime
candidate in our AP-4-deficiency model.
In sum, we reveal a critical role of AP-4 in sorting ATG9A
from the TGN in neurons. Impairment of this function as
evident in the AP-4 deficiency model leads to accumulation of
ATG9A within the TGN in vivo and in culture, leading to
a specific reduction to the axonal delivery of ATG9A. As
a result, axonal autophagosome biogenesis is defective, likely
underlying the axonal defects evident in ap4e1 KO mice.
Together, our findings provide evidence towards
a mechanism of pathology in AP-4 deficiency.
Materials and methods
Animals
ap4e1 knockout (ap4e1−/-, C57BL/6J-Ap4e1[tm1b{KOMP}Wtsi], KO)
were generated using the knockout-first tm1b allele system [71] by
the International Mouse Phenotyping Consortium (IMPC) MRC
Harwell. Animals weremaintained under controlled 12:12 h light-
dark cycles at a temperature of 20 ± 2°C with food and water ad
libitum. Genotyping was carried out using the following primers;
AP4E1-5arm-WTF: GCCTCTGTTTAGTTTGCGATG, AP4E1-
Crit-WTR: CGTGCACAGACAGGTTTGAT and 5mut-R1:
GAACTTCGGAATAGGAACTTCG. Littermate matched
controls were used for primary neuronal cultures and immuno-
cytochemistry experiments. All experimental procedures were in
accordance with UCL institutional animal welfare guidelines, and
under the UK Home Office licence in accordance with the
Animals (Scientific Procedures) Act 1986.
Antibodies and DNA constructs
Antibodies: For immunocytochemistry (ICC),
Immunohistochemistry (IHC) and western blotting (WB)
antibodies were used with the following dilutions; ACTB/
actin (Sigma, A2066; WB: 1:1,000), AP4B1 (Atlas
Antibodies, HPA028652; WB: 1:200), AP4E1 (BD
Biosciences, 612,018; WB: 1:300, ICC: 1:250), ATG9A (rabbit,
STO-219; WB: 1:2000, IF: 1:2000 [72]) and rabbit ATG9A;
(Abcam ab108338; WB: 1:1000, IF: 1:1000), ATG9A (Hamster
14F2 8B1; IF: 1:500 [72]), GAPDH (Abcam ab8245; WB:
1:10,000), GFAP (Dako, Z0334; ICC: 1:300), GFP (Nescalai
Tesque 04404–84; ICC: 1:1000), GOLGA2/GM130 (BD
Biosciences 610,822; ICC: 1:1000), GOLGA1/Golgin-97 (Cell
Signaling Technology, 13,193; ICC: 1:250), HA (12CA5 hybri-
doma; WB: 1:200, ICC: 1:100), LC3B (Abgent AP1802a; WB:
1:250), LC3B (Cell Signaling Technology D-11 3868S; IF:
1:250), MAP2 (Synaptic Systems 188–004, ICC: 1:500),
RBFOX3/NeuN (Chemicon International MAB377; IHC:
1:300), NEFH/NF200 (Abcam ab4680; IF: 1/500 IHC: 1/500),
MYC (NeuroMab 9E10; WB: 1:100, ICC: 1:100), ubiquitin
(Enzo Biosciences FK2; WB: 1/500) and WIPI2 (Ms
Monoclonal; WB: 1:250, ICC: 1:250 [73]). HRP-conjugated
anti-mouse/rabbit antibodies were used for western blotting
at 1:10,000 (Jackson Laboratories, 1,706,516/1,706,515). Alexa
Fluor-conjugated secondary antibodies for ICC, IHC and
super-resolution imaging were used as follows; anti-chicken
405 and 647 (Abcam, ab175675 and ab150175) anti-guinea
pig 405 and 647 (Abcam, ab175678 and ab150187 anti-mouse
488 and 647 (Jackson immunoresearch, 715–545-151-JIR and
715–605-151), anti-rabbit 555 and 647 (Abcam, ab1500074
and ab150063). Anti-Armenian hamster conjugated to Cy3
was used for super-resolution imaging (Jackson immunore-
search, 127–165-160).
DNA Constructs: CAG-GFP (Addgene, 16,664; deposited
by F Gage), pmRFP-LC3 [74] (Addgene, 21,075; deposited by
T Yoshimori). Full-length N-terminally MYC-tagged AP4E1
was generated by cloning the coding sequence of Ap4e1
(Cusabio; CSB-CL890772HU, cDNA clone MGC: 163,338)
into pRK5-Myc [75]. AP4E1V454X-ε was then generated by
reverse mutagenesis methods replicating the reported 2
nucleotide insertion leading to frameshift induced premature
stop at V454 [10]. HA-ATG9A was kindly gifted by the Tooze
laboratory [72].
Brain lysate preparation for co-immunoprecipitation
Lysate Preparation: Brains to be used for co-
immunoprecipitation were removed from animals and homo-
genized in ice cold HEPES buffer (50 mM HEPES [GIBCO,
15,630–056], 0.5% Triton X-100 [Sigma Aldrich T-8787],
150 mM NaCl [Fisher Scientific, 11,904,061], 1 mM EDTA
[Sigma Aldrich E5134], 1 mM PMSF [Panreac AppliChem,
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A0999,0025], 50 μl antipain, pepstatin and leupeptin [Peptide
Institute, 4062, 4367, 4041] in ddH2O). Lysate was solubilized
by rotation for 2 h at 4°C prior to ultracentrifugation at
80,000 g for 40 min. Protein content determined using
a BCA assay kit (Promega, PI-23,225).
Co-Immunoprecipitation: Brain lysate (5 mg) was incubated
with 1 μg of antibody in HEPES buffer for 12 h at 4°C with
rotation, and 1 μg IgG control (rabbit; Thermo Fisher, 02–6102)
was incubated with WT brain lysate in tandem. Input samples
were incubated in the same manner at all steps as immunopre-
cipitation samples. Protein A agarose beads (Generon, PC-A25)
were added for 4 h to IP samples, beads washed in HEPES buffer
and suspended in protein sample buffer (150 mM Tris, pH 8
[Sigma Aldrich, 93,352], 6% SDS [Fisher Scientific, 10,090,490],
300 mM DTT [Melford, MB1015], 30% glycerol [Fisher scien-
tific, 10,021,083], 0.3% bromophenol blue [Sigma Aldrich,
B0126]) and heated to 95°C for 7 min prior to SDS-Page and
western blotting.
Brain and tissue lysate preparation; SDS-PAGE and
western blotting
Lysate Preparation: Brains and tissues to be used for western
blotting were removed from animals and snap frozen at −80°
C. For preparation of lysates, brains and tissues were
defrosted, relevant regions dissected and kept on ice through-
out. Tissue was homogenized by sonication in lysis buffer
(50 mM HEPES, pH 7.5, 0.5% Triton X-100, 150 mM NaCl,
1 mM EDTA, 1 mM PMSF, antipain/pepstatin/leupeptin as
above), and debris pelleted at 38,000 x g for 10 min at 4°C.
Lysate protein content was determined using a commercial
BCA assay kit (Promega, PI-23,225) and samples denatured
for 7 min at 95°C in protein sample buffer. Samples were
stored at −80°C.
SDS-PAGE and western blotting: Protein lysate (20–40 μg)
was separated by SDS-PAGE using Xcell Minicell II systems
(Invitrogen, EI0002) and transferred onto nitrocellulose (GE
healthcare, 10,600,003) or 0.45-μm pore PVDF (for LC3; GE
Healthcare, 11,330,744). Membranes were blocked in milk
(4% non-fat milk powder [Marvel, S0942], 0.05% Tween-20
[National Diagnostics, EC-607]) in PBS (137 mM NaCl
[Fisher Scientific, 10,428,420], 2.7 mM KCl [Merck,
104,936], 10 mM Na2HPO4 [Merck, 106,586], 1.8 mM KH2
PO4 [Merck, 529,568]), pH 7.4, 3% BSA [Sigma Aldrich,
05482-100G] for LC3 and AP4E1 for 1 h and incubated with
primary antibodies at empirically determined dilutions as
above overnight with agitation at 4°C. Membranes were then
washed, secondary HRP-conjugated antibodies applied in
milk at 1:10,000 and after a final washing steps bands visua-
lized by application of ECL substrate (Millipore Luminata
Crescendo, WBLUR0500) and imaging using a CCD based
system (Quant LAS 4000, GE Healthcare). Densitometric
analysis was performed using FIJI software (NIH).
Beta-galactosidase staining of embryos, brains and
sections
Embryos and embryonic brains: Embryos to be stained with
X-gal were removed at developmental stages E12.5, E13.5 and
E15.5. Due to impermeability of embryos at E15.5, brains were
removed from animals and stained similarly to whole embryos.
Embryos and brains were washed in PBS briefly, fixed in 4%PFA
(Sigma-Aldrich, P6148-500G) for 90 min and stained at room
temperature (RT) for 18 h (5 mM EGTA [Sigma-Aldrich,
E4378], 2 mM MgCl2 [Melford, M0535], 0.2% gluteraldehyde
[Sigma-Aldrich, G5882], 0.4% PFA, 0.01% DOC [Sigma-
Aldrich, D6750], 0.02% NP40 [Millipore Calbiochem, 492,018]
in PBS). Subsequently, embryos and brains were washed in PBS
and serially dehydrated in increasing concentrations of EtOH
(50–100%), and stored at 4°C in 100% EtOH.
Adult brain X-Gal staining: Brains were removed from
adult mice and fixed similarly to embryos. Fixed brains were
washed, and 100-μm sections prepared using a vibratome
(Leica). Sections were mounted onto glass slides, stained,
washed and dehydrated similarly to embryonic brains.
Sections were mounted with cover glass using Mowiol
(Calbiochem, 475,904) medium and stored at 4°C.
Golgi-cox silver staining and neuronal reconstruction
Golgi staining: Neurons in intact brains were stained using the
Rapid GolgiStain Kit [FD Neurotechnologies, PK401].
Staining was carried out as per manufacturer’s protocols,
briefly; removed brains were impregnated with solution in
darkness, stained for 2 weeks, and sectioned using a vibratome
(Leica) at a thickness of 100 μm. Slices were transferred to
gelatin coated slides (0.3% gelatin [Sigma-Aldrich, G9391],
0.05% chromium potassium sulfate [Acros Organics,
222,521,000] in H2O) and dried. Dried slices were stained
using kit working solutions, dehydrated using increasing con-
centrations of EtOH and cleared using xylene (Fisher scien-
tific, 10,385,910) prior to mounting with per mount (Fischer
scientific, 15,832,544) and covering with coverglass.
Neuronal reconstruction: Prepared sections were imaged,
traced and analyzed using Neurolucida software (MBF
Bioscience). Neurons were traced live in X, Y and Z dimensions
using and reconstructed and analyzed using inbuilt sholl-analysis
tools within Neurolucida.
Hippocampal and cortical neuronal culture and transient
transfection
Hippocampal/Cortical neuronal cultures: Hippocampal/
Cortical cultures from crosses of heterozygous Ap4e1 animals
were prepared from embryos at E16 as described previously
[76–78]. Briefly, hippocampi and cortices were dissected in
ice-cold HBSS [Gibco, 14,180–046] supplemented with
10 mM HEPES, pH 7.5 and incubated in 0.25% trypsin
(Sigma-Aldrich, T4799) for 15 min prior to trituration.
Dissociated neurons were seeded onto poly-L-lysine (Sigma-
Aldrich, P2636; 0.5 mg/ml in 0.1 M borate buffer, pH 8)-
coated coverslips at a density of 30–50,000/cm2 in attachment
medium (10% horse serum [Gibco, 26,050,088], 10 mM
sodium pyruvate [Gibco, 11,360,070], 0.6% glucose in MEM
[Gibco, 31,095,029]). Attachment media was replaced the
next day with Maintenance medium (2% B27 [Gibco,
17,504–044], 2 mM glutamax [Gibco, 35,050,061], 100 μg/ml
Penicillin/Streptomycin [Gibco, 15,140–163] in Neurobasal
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[Gibco, 21,103,049]). Fifty percent of the maintenance med-
ium was replaced every 4 days after the first week in culture to
maintain cell health.
Transient transfection: Neurons were transfected using
lipofectamine 2000 (Invitrogen, 1,168,019) according to man-
ufacturer’s protocols, at an empirically determined ratio of
lipofectamine to DNA per construct used (GFP 0.25 μg, RFP-
LC3 0.25 μg, HA-ATG9A 1 μg and Ap4e1 constructs 1 μg per
2 coverslips, 1 μl lipofectamine per coverslip). Neurons were
left to express constructs for 2–3 days prior to further
experimentation.
Immunocytochemistry, immunohistochemistry and
fluorescent dyes
Immunocytochemistry (ICC): Hippocampal cultures on cover-
slips were fixed prior to staining with 4% PFA with 4%
sucrose (Sigma-Aldrich, S9378) in PBS for 7 min at RT. Post-
fixation coverslips were washed in PBS and permeabilized for
10 min in blocking solution (1% BSA, 10% horse serum, 0.1%
Triton X-100 in PBS). Primary antibodies were diluted in
blocking solution at empirically determined dilutions and
applied for 1 h at RT in a dark humidified chamber.
Coverslips were washed in PBS and fluorescent-conjugated
secondary antibodies as listed above were used at
a concentration of 1:1000 and applied for 1 h at RT in
a humidified chamber. Coverslips were mounted in ProLong
Gold mounting medium (Invitrogen, P36930) and allowed to
dry overnight at RT prior to imaging.
Immunohistochemistry (IHC): Brains were removed from
animals and fixed by immersion in 4% PFA for 24 h at 4°C,
cryoprotected in 30% Sucrose-PBS for 24 h and frozen and
stored at −80°C. Frozen brains were embedded into OCT
compound (Tissue-Tek, 4583) and serially cryosectioned
into 30-μm sections in a Bright OTF-AS Cryostat (Bright
Instruments) and stored at −20°C prior to staining in cryo-
protective solution (30% glycerol, 30% PEG in PBS). IHC
staining was performed with free-floating sections at RT
with gentle agitation. Sections were washed and permeabilized
in PBS-Tx (0.5% Triton X-100 in PBS) for 30 min prior to
blocking in IHC blocking solution (3% BSA, 10% FBS, 0.2 M
glycine [Fisher scientific, 10,080,160] in PBS-Tx) for 3 h.
A second block was applied for 3 h as prior but with the
addition of goat anti-mouse Fab-fragment (Jackson
Immunoresearch, 115–007-003) at 50 μg/ml to reduce endo-
genous background when using antibodies raised in mouse.
Sections were washed for 30 min and primary antibodies
applied at concentrations as listed above in IHC blocking
solution for 4 h. Sections were washed for 30 min and fluor-
escent antibodies applied for 4 h prior to a final wash and
mounting onto glass slides with Mowiol medium. Slides were
allowed to dry at RT overnight prior to imaging.
Fluorescent dyes: Free-floating sections as prepared for IHC
were washed in PBS-Tx, and incubated at RT with gentle agita-
tion for 4 h with FluoroMyelin Green (Invitrogen, F34651;
1:400) in blocking solution. Sections were washed for
3 × 30 min prior to mounting onto glass slides with Mowiol.
Slides were allowed to dry at RT overnight prior to imaging.
Autophagic flux assays
Cortical neurons were cultured onto 6-well dishes at a density
of 80,000 per well and maintained in neuronal maintenance
media as described. At DIV-8, cells were treated with 100 nM
bafilomycin A1 (VWR, 196,000), in conditioned maintenance
media, or additionally with 250 nM rapamycin (Cayman
Biotech, 53,123–88-9) for durations as indicated. EBSS condi-
tions were first washed once with EBSS (to remove excess
serum form maintenance media) followed by addition of
EBSS + bafilomycin A1. After treatment, cells were washed
once in EBSS and collected directly by addition of sample
buffer. Samples were sonicated, boiled and subjected to SDS-
PAGE and western blotting as described.
Correlative light and electron microscopy
Cells were cultured on gridded coverslip-bottomed dishes
(MatTek, P35G-1.5–14-CGRD) to facilitate correlation
between light and electron microscopy and processed for the
latter as described in [79]. Brightfield images of regions of
interest were acquired using an Olympus BX50WI upright
microscope and TEM images acquired using an FEI tecnai
G2 Spirit transmission electron microscope and an Olympus
SIS Morada CCD camera.
Live imaging, autophagosome motility analysis and
long-term live imaging
Live Imaging of autophagosome maturation: For autophago-
some maturation and motility experiments, cultured hippo-
campal neurons were transfected at DIV-4 with RFP-LC3 as
described, to be imaged at DIV 6–7. Imaging was carried
out under perfusion with ACSF (124 mM NaCl2, 2.5 mM
CaCl2 [VWR, 190464k], 2.5 mM KCl [Sigma-Aldrich,
P9541], 1 mM MgCl2 [Melfords, M0535], 10 mM
D-glucose [Fisher scientific, G/0500/53], 25 mM NaHCO3
[Sigma-Aldrich, S5761], 1 mM Na2HPO4, pH 7.4) at 37°C
with a flow-rate of 1–2 ml/min and aerated (5% CO2, 95%
O2) throughout. Growth-cones were identified and the RFP-
LC3 signal in the distal most 75 μm of axon captured using
a EM-CCD camera system (iXon, Andor technology)
mounted to an Olympus microscope (BX60M) with a 60x
objective, as described previously [75]. A mercury arc lamp
with filtering provided excitation of the RFP fluorophore
(Cairn Research). Images were acquired using
MicroManager (Opensource, Micro-manager.org) [80] for
6 min at 1 frame every 1.5 s.
Autophagosome motility analysis: Movies generated from
distal axons used to generate kymographs using the ‘Multiple
Kymograph’ plugin. Resulting kymographs represent autop-
hagosome motion as time on the Y axis (1.5 s/px) and dis-
tance on the X (0.1333 μm/px). Trajectories were manually
tracked and analyzed using an in-house MATLAB script.
Briefly, the motion of an autophagosome is possible to define
precisely by the positional change from co-ordinates x1/y1 to
x2/y2. Calculating all of the individual trajectory changes for
an individual autophagosome’s track we were able to ascer-
tain; velocity, proportion of time spent moving, directionality
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etc. Per track, portions of time spent moving at less than 0.05
μm/s were classed as stationary.
Long-term live imaging: Neurons were seeded onto Poly-
L-Lysine coated 96-well plates (Ibidi, 89,626), transfected with
CAG-GFP at DIV-3/4 as described and imaged 2 days later
using an ImageXpress Micro XLS imaging system
(MolecularDevices) with environmental control. Timelapse
movies were taken from up to 16 different fields per well at
a rate of 1 frame every 5 min for 6 h (72 frames). Eight-bit
images were recorded, movies generated using a custom
ImageJ plugin, and regions with growing axons cropped for
analysis.
Structured illumination imaging (SIM)
SIM was performed on a commercially developed Zeiss Elyra
PS.1 inverted microscope using a Zeiss 63x oil objective lens
(NA: 1.4) and pco.edge CMOS camera and ZEN Black soft-
ware (Zeiss) as described previously [78,79]. Images were
captured using SIM paradigms (34-μm grating, 3 rotations
and 5 lateral shifts) and processed using the SIM reconstruc-
tion module within ZEN Black with default theoretical PSF
and other settings. Shifts between acquired channels were
corrected for using 100-nm Tetraspeck fluorescent micro-
spheres (Invitrogen, T7279).
Image analysis
All imaging and image analysis techniques were performed
blinded. All WT and KO embryos generated per genotype
were used, and cell numbers kept consistent between embryos
rather than genotypes (as a result of blinding at acquisition
stage). Between 3 and 6 images were taken per condition and
samples sizes kept consistent across experimental techniques.
All microscopic imaging unless stated otherwise was using an
upright Zeiss LSM700 confocal microscope. Images were digi-
tally captured using Zen 2010 Software (Zeiss), using oil
immersion objectives: 63x; 1.4 NA, 40 × 1.3 NA and air
objectives; 10 × 0.3 NA, 5 × 0.16 NA.
Brain measurements: Quantification of the thickness and
lengths of axonal tracts was performed manually using Fiji. At
least 2 brain sections per animal were analyzed and the mean
measurement used as the representative value.
Axonal Length, Branching and swellings: GFP-filled neurons
at DIV-4 were fixed and imaged using a 40x objective, and
images stitched using ‘MosaicJ’ or ‘Pairwise stitching’ [81] plu-
gins in FIJI as required. Entire lengths of axons including all
branches wasmeasuredmanually using FIJI, and branches quan-
tified excluding any process below 20 μm. Axonal swellings were
defined as a compartment > 2x the width of the axon shaft, and
numbers counted manually. For DIV-14 swellings quantifica-
tion, fields of view were captured, total axonal length and num-
bers of swellings present within the field captured were counted
to determine swellings per 100 μm of axon.
Dendritic morphology and complexity: DIV-14 GFP-filled
neurons were fixed and imaged, and images stitched as pre-
viously described where necessary. Dendritic morphology was
reconstructed using Neuronstudio (CNIC) and inbuilt analy-
sis tools used to ascertain total dendritic length and branches
as described previously [75,82]. Sholl analysis of intersections
was performed using the ‘Simple Neurite Tracer’ plugin in
FIJI, with a sholl radius of 10 μm. Images were stitched where
necessary.
Nascent dendritic length and branching: DIV-4 GFP filled
neurons were reconstructed using Neuronstudio and total
length and branches of nascent dendritic processes per neu-
ron quantified using inbuilt tools.
ICC quantification of total fluorescent signal: For quantifi-
cation of dendritic and axonal vesicle numbers, regions posi-
tive for compartment markers (MAP2 and NEFH/NF200
respectively) were outlined manually per image, and values
normalized to area. Total fluorescence of ATG9A was quanti-
fied by outlining the cell soma and measuring total fluores-
cence using inbuilt FIJI tools. GFAP immunoreactivity was
quantified using total fluorescence per hippocampal region.
Neuronal cell number quantification: For neuronal cell
number measurements, sections stained against RBFOX3/
NeuN were imaged and RBFOX3/NeuN-positive cells
counted. For relative cortical neuronal density, 100-μm wide
columns of the cortex were cropped and counted (2 sections
per animal); for regions of the hippocampus, 30 μm regions
were cropped and counted (2 sections per animal).
Puncta size, number and association: For quantification of sizes
and numbers of puncta, DIV-8 hippocampal neurons were
stained using relevant antibodies and processed and imaged as
described. Puncta size and number were analyzed using in-built
tools withinMetamorph software (Molecular Devices). Signals for
LC3 and WIPI2 were blindly thresholded over entire sample sets,
punctamanually segmented where required (when overlapping or
in indiscernible proximity when threshold applied) and puncta
number and area quantified with an exclusion cut-off set at 0.05
μm2. Puncta association (WIPI2 and LC3) was quantified using
inbuilt integrated co-localization tool.
Statistical analysis
Results were analyzed using Graphpad Prism 6 (Graphpad
Software Inc). Data is presented as mean ± SEM. Where
normalized, values are presented relative to the average of
control values unless stated otherwise. Data was tested for
normality prior to statistical testing, and appropriate statistical
tests used. For differences between 2 groups statistical signifi-
cance was determined using unpaired two-tailed Student’s
t-tests when parametric. Two groups were tested using two-
tailed Mann-Whitney U tests where at least one group was
non-parametric. For 3 or more groups, statistical significance
was determined by two-way ANOVAs with Bonferroni post-
hoc testing where data was parametric. Kruskall-Wallis
H tests were used for comparison of three or more groups
where at least 1 group was non-parametric. Significance is
represented as; p* < 0.05, p** < 0.01 and p*** < 0.001.
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